Senior insider sale
Chief Technology Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$95.8K
11.91K shares
What this filing means
HARMON CYRUS plans to sell 11.91K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $95.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2025ACC: 0001959173-25-006056
DirectorOfficer· Chief Technology Officer
Since Nov 2020
11.91K
Shares to sell
$95.8K
Approx. market value
11.91K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Open Market Purchase
Cash
6/30/2014
1.91KFounder Shares
Compensation
3/20/2007
10KTotal acquired11.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2014 | Open Market Purchase Cash | 1.91K | — |
3/20/2007 | Founder Shares Compensation | 10K | — |
| Total | 11.91K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.91K
Market value
$95.8K
9/16/2025
Total
Units
11.91K
Value
$95.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/16/2025 | 11.91K | $95.8K | NASDAQ | Planned |
| Total | 11.91K | $95.8K | ||